Prevalence and clinical relevance of familial hypercholesterolemia-causing mutations in Germany

4 April 2025 (11:00 - 11:45)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Natalie Arnold

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

5 More presentations in this session

Presentation thumbnail

Gender differences in the management of dyslipidemia in Switzerland

Doctor R. de La Harpe (Lausanne, CH)

Abstract Slides

Presentation thumbnail

More musculoskeletal disorders and poor pain management in patients with familial hypercholesterolemia and self-perceived side effects to cholesterol-lowering treatment

Ms A. Uduma (Oslo, NO)

Abstract Slides

Presentation thumbnail

Monetary costs and LDL-C reduction from upfront combination lipid-lowering therapy with ezetimibe in an irish ACS cohort

Doctor D. Butler (Galway, IE)

Abstract Slides

Presentation thumbnail

Evaluation of LDL levels and lipid optimisation in high cardiovascular risk patients in nurse-led clinics in Ireland: a cross-sectional study

Mrs M. Brennan (Waterford, IE)

Abstract Slides

Presentation thumbnail

Comparative effectiveness of novel anti-hyperlipidemic drugs in adults with hyperlipidemia: a systematic review and bayesian network meta-analysis

Doctor V. Lanari (Milan, IT)

Abstract Slides

Access the full session

Session thumbnail

Dyslipidaemia management in 2025: status quo and best practice (2)

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 11:00 CET

You may be interested in

Webinar

Risk assessment and lipid management in primary prevention

Webinar

Unmet needs in lipid management: treatment goals and how to achieve them

Webinar

Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources